U.S., Sept. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07157475) titled 'Vascular Complications in Patients Undergoing Peripheral Revascularization and Taking SGLT-2 Inhibitors' on Aug. 18.
Brief Summary: The study is observational and involves patients (pts) with peripheral arterial occlusive disease (PAD) who have undergone lower limb revascularization procedures. Patients who are at least one year post-procedure will be contacted by phone and asked whether any cardiovascular complications occurred during that period, specifically major adverse cardiovascular events (MACE) or major adverse limb events (MALE), and whether they had been taking sodium-glucose co-transporter 2 inhibitors (SGLT2-i, "flozins...